跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18 条关于
“CLINUVEL”
全部
18
临床试验
0
药物
1
机构
5
资讯
12
去年
Clinuvel Seeks EMA Approval for Increased SCENESSE Dosage in Europe
11个月前
CLINUVEL Advances Novel Sustained-Release Peptide Formulations to Preclinical Testing
去年
CLINUVEL CEO Returns to Drive US Expansion with Vitiligo Treatment Approval Strategy
去年
CLINUVEL Seeks Canadian Approval for SCENESSE® in Erythropoietic Protoporphyria
去年
Clinuvel Advances Phase III Trial for Vitiligo Treatment with SCENESSE®, Recruiting Over 200 Patients
2个月前
Clinuvel Announces Strategic Restructure and US Relocation to Unlock Pipeline Value, Led by Vitiligo Program
4个月前
CLINUVEL Receives EMA Scientific Advice for Pivotal Phase III Vitiligo Study Using "Totality of Evidence" Approach
2个月前
SCENESSE® (Afamelanotide) Approved by Health Canada for Erythropoietic Protoporphyria
去年
Vitiligo Treatment Pipeline Shows Promise with JAK Inhibitors and Novel Immunotherapies in Phase 3 Trials
去年
Patient-Researcher's Journey Leads to Breakthrough Treatment for Rare Light Sensitivity Disorder
第 1 页,共 2 页
上一页
下一页